Measles vaccination

Measles vaccination refers to active immunization indicated for the prevention of measles (rubeola), a highly contagious systemic viral infection caused by the measles morbillivirus of the family Paramyxoviridae Transmitted via respiratory droplets and airborne aerosols, the pathogen initially infects the respiratory epithelium and lymphoid tissue before disseminating systemically

Measles vaccination refers to active immunization indicated for the prevention of measles (rubeola), a highly contagious systemic viral infection caused by the measles morbillivirus of the family Paramyxoviridae

Measles vaccination refers to active immunization indicated for the prevention of measles (rubeola), a highly contagious systemic viral infection caused by the measles morbillivirus of the family Paramyxoviridae

The disease primarily affects non-immune pediatric and adult populations, presenting clinically with high fever, malaise, the classic triad of cough, coryza, and conjunctivitis, followed by pathognomonic Koplik spots and a maculopapular exanthem Severe complications include secondary bacterial or viral pneumonia, otitis media, acute encephalitis, and late-onset subacute sclerosing panencephalitis

The disease primarily affects non-immune pediatric and adult populations, presenting clinically with high fever, malaise, the classic triad of cough, coryza, and conjunctivitis, followed by pathognomonic Koplik spots and a maculopapular exanthem

The disease primarily affects non-immune pediatric and adult populations, presenting clinically with high fever, malaise, the classic triad of cough, coryza, and conjunctivitis, followed by pathognomonic Koplik spots and a maculopapular exanthem Severe complications include secondary bacterial or viral pneumonia, otitis media, acute encephalitis, and late-onset subacute sclerosing panencephalitis